Moderna to Present at Upcoming Conference in June 2026
-
UN warns world to prepare for El Nino extreme weather
-
Liverpool legend Dalglish reveals cancer treatment
-
Iran World Cup squad to head for Mexico via Spain
-
Israel says US backs striking Beirut suburbs if Hezbollah attacks
-
French astronaut to fly to commercial space station under deal
-
Bologna announce Tedesco as new coach, replacing Italiano
-
Oil falls, stocks rise as traders bet on Mideast progress
-
Liverpool close to hiring Iraola: reports
-
'Nightmare': Russian attacks kill 18 across Ukraine
-
Southampton boss Eckert takes blame for 'spygate' scandal
-
Israel risks new quagmire in Lebanon
-
Mozambique says five citizens killed in S. Africa 'xenophobic attacks'
-
Exoplanets can have magnetic fields, 'hot Jupiter' winds reveal
-
Chelsea's French star ready to attack World Cup with gusto
-
Kenyan president defends US Ebola centre amid protests
-
England cricket legend Flintoff named Sydney Thunder head coach
-
Southampton coach Eckert takes blame for 'spygate'
-
Most stocks rise, oil drops as traders assess outlook for Mideast deal
-
Russian missile, drone barrage kills 13 across Ukraine at night
-
Saints owner sticks by manager despite 'spygate' scandal
-
Most stocks rise as traders assess outlook for Mideast deal
-
Russian missile, drone barrage kills 11 across Ukraine at night
-
Pay workers 'as much as possible', Nvidia's Huang says
-
Israel, Hezbollah clash ahead of US-hosted talks
-
Indie horror flicks 'Obsession' and 'Backrooms' draw Gen Z to cinema
-
French wine growers plant trees to protect vines from climate
-
Fears of hunger overwhelm Guatemalan village as El Nino approaches
-
Between ballet and war: Japanese dancers pursue dreams in Russia
-
Ukrainian haiku poet finds small miracles in war
-
'Messi, Maradona, Tim': NZ footballer's viral fan club hits 4 million
-
For Roland Garros youth, quarter-final moment of truth
-
Asian stocks swing on mixed signals over Middle East
-
Russian missiles rock Kyiv, kill several in eastern Ukraine
-
Bollywood divided over bid to cap punishing work hours
-
Hanoi curbs kerb culture as city clamps down on pavement vendors
-
Peru votes in tight runoff as Fujimori makes fresh bid for power
-
As Trump cheerleads for AI, some in MAGA world fret
-
AI unearths football talent beyond scouts' radar
-
Euphrates flood deprives east Syria farmers from crops
-
Vital to keep a UN force in Lebanon after current peacekeepers depart: Guterres
-
Australia says wheat crop set to plunge
-
OneMeta Signs Government Emergency Services Agreement in Mexico for FIFA 2026 Deployment of VerbumLocal(TM)
-
374Water Advances the Solution to the World's Growing Biosolids Problem with Successful Factory Acceptance Test for Orange County Sanitation District
-
The Clock Is Running on Life Safety Lines: What POTS Retirement Means for Your Building's Emergency Communications
-
Critical Elements Announces Participation in THE Mining Investment Event, Quebec City, June 2-4, 2026
-
The Alkaline Water Company Signs Letter of Intent to Acquire Eureka Beverages Inc., Expanding Canadian Manufacturing and Private Label Platform
-
KIDZ AI Announces Strategic Treasury Pivot to Hyperliquid Ecosystem and Yield-Bearing Stablecoin Strategies
-
Silver X Intersects 40.71 m True Width at 98.7 g/t AgEq (69.53 g/t Ag, 0.87% Pb, 0.28% Zn) at Blenda Rubia, Including 4.12 m of 274.5 g/t AgEq
-
The Eastern Company Acquires Sungear and Crown Precision
-
Moderna to Present at Upcoming Conference in June 2026
Moderna to Present at Upcoming Conference in June 2026
CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Goldman Sachs 47th Annual Global Healthcare Conference 2026, on Tuesday, June 9th at 3:20 p.m. ET
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
A.Malone--AMWN
